← Open Payments lookup

CHRISTINE BOYET: Open Payments

NPI 1922571967 · FRANKLINTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,427 in 100 payments from 25 companies in 2025. Trend: 2023 $1,741 · 2024 $1,950 · 2025 $2,427

Food & beverage: $2,427
CompanyPaymentsAmount
ABBVIE INC.15$401
AstraZeneca Pharmaceuticals LP8$355
Lilly USA, LLC10$233
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$197
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$163
Supernus Pharmaceuticals, Inc.10$157
Novo Nordisk Inc9$136
Astellas Pharma US Inc6$130
Madrigal Pharmaceuticals1$112
Ardelyx, Inc.1$89

Products named: BREZTRI, VRAYLAR, CAPLYTA, XIFAXAN, Qelbree, FARXIGA, Veozah, MOUNJARO.

Industry payments across LA — which companies pay providers there.